Boston, MA -- (SBWIRE) -- 01/13/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Growlife Inc (OTCBB:PHOT), Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT)
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) decreased -0.39% at the price of $71.11 recently on a traded volume of 165,226.00 shares, in comparison to 628,191.00 shares of average trading volume. So far this year, the stock is up over 1.3%.
The company has a total market capitalization of $245.35 billion and its total outstanding shares are 3.45 billion. Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world.
Has RHHBY Found The Bottom and Ready To Move Up? Find Out Here
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) soared 15.97% at the trading price of $2.77 on a traded volume of 761,318.00 shares till now, whereas its average trading volume is 1.93 million shares. In the last three months, the stock is up 318.18%. The Intra-day range for the stock is $2.70 and $2.81. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications.
For How Long PVCT Gloss will Attract Investors? Find out via this report
Growlife Inc (OTCBB:PHOT) jumped up 25.57% at the $0.275 recently. So far in three months, the stock is up 341.97%. The 52-week range for the stock is $0.0042 and $0.467. Its introductory price for the day was $0.2375, with the overall traded volume of 3.56 million shares. GrowLife, Inc. (GrowLife) is a holding company with multiple operating businesses that manufacture and supply branded equipment and expendables in the United States for urban gardening, inclusive of equipment and expendables for growing of medical marijuana.
Will PHOT Continue To Move Higher? Find Out Here
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) after opening its shares at the price of $7.61, jumped up 9.39% , its recent trading price was $8.04 for the day. The stock moved on a traded volume of 3.56 million shares, in comparison to 1.54 million shares of average trading volume.
The 52-week range for the stock is $1.19 and $15.90. Its introductory price for the day was $7.61. Oxygen Biotherapeutics, Inc. (Oxygen Biotherapeutics) is engaged in the business of developing biotechnology products with a focus on oxygen delivery to tissue. As of April 30, 2011, the Company is developing Oxycyte, a systemic perfluorcarbon (PFC), product.
Why Should Investors Buy OXBT After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)